A new method uses the auxin-inducible degron (AID) system to tune protein levels with precision in living C. elegans.

Pairing a drug that targets the PRDM9 gene with a cholesterol-lowering agent shrank brain tumors and improved survival in mice.

Results open the door to therapies based on chronobiology, the branch of biology that studies how living organisms structure their physiological processes in time.

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...

High-quality genome assemblies and CRISPR editing were used in goldenberries to generate more compact and manageable plants.

Researchers at Concordia University say they are now able to bring promising innovations from concept to pilot under one roof.

Organoids with both intestinal and colonic regions are able to better represent the human GI tract with Ebola and Marburg infections.

STEM-engineered CAR T cells performed as well as or better against cancer cells than did FDA-approved CAR T cells and kept their cancer-fighting abilities for longer.

Their data suggests that tweaking the expression of FDX2 could make up for the loss of frataxin, the protein tied to FA's development.

By manipulating this pathway, scientists may be able to tweak the immune response to treat cancers, autoimmune disorders, and more.

AIphafold helps make the first major inroad to date towards a new and more effective way to fight the monkeypox virus.